fr-901379 and Disease-Models--Animal

fr-901379 has been researched along with Disease-Models--Animal* in 2 studies

Other Studies

2 other study(ies) available for fr-901379 and Disease-Models--Animal

ArticleYear
FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
    Bioorganic & medicinal chemistry letters, 2001, Feb-12, Volume: 11, Issue:3

    The synthesis and biological properties of a novel water-soluble echinocandin-like lipopeptide, FR131535, are described. This compound displayed potent in vitro and in vivo antifungal activities. The hemolytic activity of FR901379 was reduced by replacing the acyl side chain. This compound showed good water-solubility, comparable to the natural product FR901379.

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bronchogenic Cyst; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Female; Fungal Proteins; Glucosyltransferases; Hemolysis; Membrane Proteins; Mice; Mice, Nude; Peptides; Peptides, Cyclic; Pneumonia, Pneumocystis; Schizosaccharomyces pombe Proteins; Solubility

2001
Therapeutic effects of water-soluble echinocandin compounds on Pneumocystis pneumonia in mice.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    The therapeutic effectiveness of water-soluble echinocandin compounds obtained from Coleophoma empetri F-11899, which has a strong inhibitory effect on the growth of fungi, was examined in nude mice with experimental Pneumocystis pneumonia. The studies demonstrated the potential usefulness of the compounds.

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Microbial Sensitivity Tests; Peptides, Cyclic; Pneumocystis; Pneumonia, Pneumocystis; Rats

1998